Alan H. Auerbach, President and CEO, 10% Owner at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 34,950 shares at $5.84 ($205K) on 2026-01-06, disclosed to the SEC on 2026-01-08.
Scheduled sale ($205k) by President and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.84 | 16,938 | $99K | 48.3% |
| 2 | $5.88 | 18,012 | $106K | 51.7% |
| Total | $5.86 avg | 34,950 | $205K | 100% |
| Filing → |
| PBYI | SELL | 2025-01-03 | $213K | — | Filing → |
| PBYI | SELL | 2024-07-18 | $81K | — | Filing → |
| PBYI | SELL | 2024-07-02 | $124K | — | Filing → |